Everolimus for preventing organ rejection in liver transplantation

  • Technology appraisal guidance
  • TA348
  • Published: 
Download (PDF)

What has NICE said?

Everolimus (Certican) is not recommended for preventing organ rejection in people having a liver transplant.

What does this mean for me?

If you are already taking everolimus for preventing organ rejection after a liver transplant, you should be able to continue taking it until you and your doctor decide it is the right time to stop.

Additional resources

  • Information Standard

This page was last updated: